144 related articles for article (PubMed ID: 15029262)
1. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.
Eren F; Celikel C; Güllüoğlu B
Pathol Oncol Res; 2004; 10(1):47-51. PubMed ID: 15029262
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
Deveci MS; Deveci G
Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.
Nabizadeh Marvast M; Sima HR; Ghaffarzadehgan K; Taghizadeh Kermani A; Norouzi N
J Gastrointest Cancer; 2011 Mar; 42(1):5-10. PubMed ID: 20922580
[TBL] [Abstract][Full Text] [Related]
4. [Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].
Xu F; Liu Q; Han F; Xu E; Lai M; Zhao Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):24-30. PubMed ID: 27045237
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
[TBL] [Abstract][Full Text] [Related]
7. A composite adenoendocrine carcinoma of the stomach arising from a neuroendocrine tumor.
Ronellenfitsch U; Ströbel P; Schwarzbach MH; Staiger WI; Gragert D; Kähler G
J Gastrointest Surg; 2007 Nov; 11(11):1573-5. PubMed ID: 17436049
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.
Gajra A; Tatum AH; Newman N; Gamble GP; Lichtenstein S; Rooney MT; Graziano SL
Lung Cancer; 2002 May; 36(2):159-65. PubMed ID: 11955650
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.
Urano N; Fujiwara Y; Doki Y; Tsujie M; Yamamoto H; Miyata H; Takiguchi S; Yasuda T; Yano M; Monden M
Gastric Cancer; 2006; 9(1):44-9. PubMed ID: 16557436
[TBL] [Abstract][Full Text] [Related]
10. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
Domori K; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neuroendocrine components in gastric carcinomas.
Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
[TBL] [Abstract][Full Text] [Related]
12. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
[No Abstract] [Full Text] [Related]
14. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in cervical carcinoma.
Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
[TBL] [Abstract][Full Text] [Related]
17. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.
Brouland JP; Manivet P; Brocheriou-Spelle I; Wassef M; Le Bodic MF; Lavergne A; Launay JM
Endocr Pathol; 2001; 12(1):77-86. PubMed ID: 11478272
[TBL] [Abstract][Full Text] [Related]
18. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein as a prognostic factor in patients with gastric cancer.
Victorzon M; Nordling S; Haglund C; Lundin J; Roberts PJ
Eur J Cancer; 1996 Feb; 32A(2):215-20. PubMed ID: 8664030
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
Blumenfeld W; Chandhoke DK; Sagerman P; Turi GK
Arch Pathol Lab Med; 1996 May; 120(5):478-81. PubMed ID: 8639052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
